DCAL — Dishman Carbogen Amcis Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Dishman Carbogen Amcis, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	19,120	21,407	24,129	26,158	27,115
Cost of Revenue
Gross Profit	13,874	16,015	17,866	18,914	20,913
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	19,517	21,255	23,556	26,304	25,431
Operating Profit	-397	152	573	-146	1,685
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-650	-42.5	-546	-1,223	193
Provision for Income Taxes
Net Income After Taxes	-1,651	180	-298	-1,535	32.4
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1,651	180	-298	-1,535	32.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,651	180	-298	-1,535	32.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3.97	7.48	3.16	-6.39	1.42